Revolutionizing Alzheimer's Detection: India Embraces New FDA-Approved Blood Test for Early Diagnosis
The Dawn of a New Era: Why This Decade Could Redefine Alzheimer's Treatment
FDA Greenlights At-Home Leqembi: A Game-Changer for Early Alzheimer's Treatment
A Glimpse into the Future: How Your Eyes Could Reveal Alzheimer's Years Before Symptoms
Prothena's PRX012 Alzheimer's Drug Shines with 'Non-Competitive' Brain Swelling Rates, Offering New Hope